Carregant...
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
Clinical evidence indicates that drug resistance is a great obstacle in breast cancer therapy. It renders the disease uncontrollable and causes high mortality. Multiple mechanisms contribute to the development of drug resistance, but the underlying cause is usually a shift in the genetic composition...
Guardat en:
| Publicat a: | Adv Sci (Weinh) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6010891/ https://ncbi.nlm.nih.gov/pubmed/29938175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.201700964 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|